| Name | Title | Contact Details |
|---|
Dallas Endoscopy Center is a Dallas, TX-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
E&M Devices Inc. is a Berkeley, CA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Nava Health is a vertically integrated, tech-enabled healthcare practice that combines integrative, functional, preventive, and regenerative medicine to optimize health and increase longevity.
Dentium USA is a Cypress, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
DiagnoCure (TSX: CUR; OTCQX: DGCRF) is a life sciences corporation that develops and commercializes high-value cancer diagnostic tests that increase clinician and patient confidence in making critical treatment decisions. In 2008, the Corporation launched a colorectal cancer staging test through its U.S. CLIA laboratory. PrevistageTM GCC is currently available for licensing. The Corporation has granted a worldwide exclusive license on the diagnostic applications of its proprietary molecular biomarker PCA3 to Gen-Probe, now a wholly-owned subsidiary of Hologic Inc. Hologic Gen-Probe's PROGENSA® PCA3 prostate cancer test is commercialized in Europe under CE mark and is approved for commercialization in Canada and the United States.